MedTrace Logo

Clinical Trial of Anti-PLA2R-IgG Detection Kit (Time-resolved Fluorescence Immunoassay)

NCT06456801 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 219

Last updated 2024-06-13

No results posted yet for this study

Summary

Conduct comparative experimental studies on clinical serum samples using assessment reagents and approved products, and evaluate the equivalence between assessment reagents and comparison reagents.

Conditions

  • Nephropathy

Sponsors & Collaborators

  • Zhejiang University

    lead OTHER

Principal Investigators

  • Xiaoying Du · Zhejiang University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2021-10-01
Completion
2021-10-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06456801 on ClinicalTrials.gov